In conclusion, we observe increased differentiation of CXCR5+PD‐1+ CD8 T cells combined with a lower expression of PD‐1 in CLL, but not in other NHL with better response rates to PD‐1 ICB. This evidence concerns the gene CXCR5 and B-cell chronic lymphocytic leukemia.